DarioHealth (DRIO) Stock Price, News & Analysis

Company Overview

DarioHealth Corp. is a digital health company that develops technology-enabled solutions for managing chronic and other health conditions. Its platform combines mobile applications, connected devices, data analytics and personalized coaching to help individuals monitor their health and follow treatment and lifestyle-management plans.

The company’s offerings have included solutions for diabetes, hypertension, weight management and musculoskeletal conditions. Depending on the program, users may access connected monitoring devices, digital tracking tools, behavioral support, educational content and care-management services through a smartphone-based experience.

DarioHealth primarily serves consumers through employers, health plans, health-care providers and other organizational partners. The company was formerly known as LabStyle Innovations Corp. and adopted the DarioHealth name as it expanded its digital chronic-care platform. Its solutions are designed for use across international markets, although availability may vary by product and partner arrangement.

Key Stats

• Today's Range: $7.03 to $7.20
• 50-Day Range: $6.53 to $7.90
• 52-Week Range: $5.84 to $17.74
• Volume: 28,212 shs
• Average Volume: 27,045 shs
• Market Capitalization: $70.56 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.00
• Consensus Rating: Hold

DarioHealth Stock Analysis - MarketRank™

DarioHealth scored higher than 75% of companies evaluated by MarketBeat, and ranked 147th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Hold

Consensus Rating

DarioHealth has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

DarioHealth has a consensus price target of $10.00, representing about 38.9% upside from its current price of $7.20.

Amount of Analyst Coverage

DarioHealth has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for DarioHealth are expected to grow in the coming year, from ($2.94) to ($2.17) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of DarioHealth is -1.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of DarioHealth is -1.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

DarioHealth has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.79% of the float of DarioHealth has been sold short.

Short Interest Ratio / Days to Cover

DarioHealth has a short interest ratio ("days to cover") of 2.88, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in DarioHealth has recently decreased by 9.36%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

DarioHealth does not currently pay a dividend.

Dividend Growth

DarioHealth does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for DarioHealth this week, compared to 3 articles on an average week.

Company Ownership

• Score: 3.4 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $100,000.00 in company stock, which represents 0.1417% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, DarioHealth insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,000.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

3.50% of the stock of DarioHealth is held by insiders.

Percentage Held by Institutions

33.39% of the stock of DarioHealth is held by institutions.

Company Calendar

• Last Earnings: 8/11/2026
• Today: 9/19/2026
• Next Earnings (Estimated): 11/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:DRIO
• CIK: 1533998
• Web: www.mydario.com
• Phone: +97247706377
• Fax: 972-4770-4059
• Employees: 165
• Year Founded: 2011

Price Target and Rating

• Average Price Target for DarioHealth: $10.00
• High Price Target: $12.00
• Low Price Target: $8.00
• Potential Upside/Downside: +38.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($6.13)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$41.71 million
• Net Margins: -169.87%
• Pretax Margin: -167.64%
• Return on Equity: -54.81%
• Return on Assets: -33.36%

Debt

• Debt-to-Equity Ratio: 0.56
• Current Ratio: 2.31
• Quick Ratio: 1.92

Sales & Book Value

• Annual Sales: $22.36 million
• Price / Sales: 3.16
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $10.05 per share
• Price / Book: 0.72

Miscellaneous

• Outstanding Shares: 9,800,000
• Free Float: 9,457,000
• Market Cap: $70.56 million
• Optionable: No Data
• Beta: 1.12